Dai Yamanouchi, MD, PhD
Associate Professor
- Division of Vascular Surgery
yamano@surgery.wisc.edu
(608) 265-4420
600 Highland Ave
BX3236 Clinical Science Center
Madison, WI 53792
Education
- MD, Gunma University, Japan, 2000
- PhD, Gunma University, Japan, 2006
- Surgical Internship and Residency, Gunma University Hospital, Japan, 2000-2003
- Surgical Residency, Saiseikai Maebashi Hospital, Japan, 2001-2002
- Research Fellowship, Nagoya University Graduate School of Medicine, Japan, 2003-2004
- Clinical Fellowship in Vascular Surgery, Nagoya University Hospital, Japan, 2004-2007
- Research Fellowship, Weill Cornell Medical College, New York, NY, 2007-2008
- Fellowship in Advanced Endovascular Surgery, University of Wisconsin Madison, Madison, WI, 2009-2010
Clinical Specialties
Dr. Yamanouchi specializes in vascular and endovascular surgery. He is board certified in angiology and endovascular surgery in Japan.
Dr. Yamanouchi specializes in open and endovascular techniques for the treatment of vascular diseases. His expertise includes treatments for aortic aneurysms, carotid disease, aortic dissection, peripheral arterial disease, and other vascular disorders.
Dr. Yamanouchi provides a wide range of services including Abdominal Aortic Aneurysm (AAA) Repair – Endovascular, Abdominal Aortic Aneurysm (AAA) Repair – Open, Amputation, Angioplasty With Stent Placement, Carotid Endartecotomy, Carotid Stenting, Extended Efforts in Limb Salvage, Peripheral Artery Bypass, Thoracic Aortic Aneursym – Endovascular, Thoracic Aortic Aneursym – Open, Thoracic Outlet Syndrome Treatment, Varicose Vein Treatment.
Research Interests
Dr. Yamanouchi’s research interests include the pathogenesis of abdominal aortic aneurysm and restenosis after angioplasty including balloon angioplasty and stent placement. He is also devoted to the development of novel materials for vascular bypass graft and gene delivery method to treat the patients who suffer peripheral arterial disease. In addition, Dr. Yamanouchi serves as principal investigator on a number of clinical trials.
Recent Publications
The inhibition of Wnt signaling attenuates RANKL-induced osteoclastogenic macrophage activation.
Yamanouchi D, Igari K
Vasc Biol 2023 Jul 13; 5(1)
[PubMed ID: 37314315]Unpacking the Complexities of a Silent Killer.
Yamanouchi D
Int J Mol Sci 2023 Apr 12; 24(8)
[PubMed ID: 37108288]Induction of endoplasmic reticulum stress markers in an acromegaly model.
Elbialy A, Sulidan K, Bhuiyan A, Igarashi Y, Yoshitake K, Yamanouchi D, Kang J, Asakawa S, Watabe S, Kinoshita S
J Cell Biochem 2022 Sep; 123(9): 1411-1421
[PubMed ID: 35734917]Effects of Ultrafine Single-Nanometer Oxygen Bubbles on Radiation Sensitivity in a Tumor-Bearing Mouse Model.
Gombodorj N, Yokobori T, Mutsuki N, Erkhem-Ochir B, Okami H, Asao T, Saeki H, Shirabe K, Yamanouchi D
Int J Mol Sci 2022 Jun 20; 23(12)
[PubMed ID: 35743281]Injectable Hydrogel Capable of In Situ Covalent Crosslinking for Permanent Embolization.
Xie R, Chen YC, Zhao Y, Yodsanit N, Wang Y, Yamamoto N, Yamanouchi D, Gong S
ACS Appl Mater Interfaces 2021 Dec 08; 13(48): 56988-56999
[PubMed ID: 34806359]